The Transcreener® HTS Assay platform overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by utilizing a single set of assay reagents that detect an invariant product. The generic nature of the Transcreener® HTS Assay platform eliminates delays involved in assay development for new HTS targets, and greatly simplifies compound and inhibitor profiling across multiple target families. The Transcreener® GDP Assay is a far-red, competitive fluorescence polarization (FP) assay based on the detection of GDP and therefore is compatible with any enzyme that produces GDP, including GTPases such as CDC42. The Transcreener® GDP Assay is a simple one step homogenous detection assay, and is extremely flexible with regard to GTP concentration (1 to 1,000 µM GTP). The assay provides excellent signal at low substrate conversion, with a Z’; = 0.7 and =85 polarization shift (mP) at 10% GTP conversion using 10 µM GTP. The Transcreener® GDP Assay was developed to follow the progress of any enzyme that produces GDP. The Transcreener® GDP Detection Mixture comprises a GDP Alexa633 Tracer bound to a GDP Antibody. The tracer is displaced by GDP, the invariant product generated during the enzyme reaction. The displaced tracer freely rotates leading to a decrease in fluorescence polarization. Therefore, GDP production is proportional to a decrease in polarization. The assay uses a far red tracer to minimize interference from fluorescent compounds and light scattering.View full Transcreener® product list
Legal Information
Transcreener is a registered trademark of BellBrook Labs